FTC’s $448m AbbVie win overturned


Rory O'Neill

FTC’s $448m AbbVie win overturned

Piotr Swat / Shutterstock.com

A US appeals court has cancelled a $448 million antitrust bill for AbbVie, in a blow for the US Federal Trade Commission (FTC).

FTC, AbbVie, antitrust, US District Court for the Eastern District of Pennsylvania, Besins healthcare, monopoly, FDA, reverse payment, lawsuit, en banc